Faux M C, Rollins E N, Edwards A S, Langeberg L K, Newton A C, Scott J D
Howard Hughes Medical Institute, Vollum Institute, L474, Oregon Health Sciences University, 3181 SW Sam Jackson Park Road, Portland, OR 97201, USA.
Biochem J. 1999 Oct 15;343 Pt 2(Pt 2):443-52.
The A-kinase-anchoring protein AKAP79 co-ordinates the location of cAMP-dependent protein kinase, phosphatase 2B (PP2B/calcineurin) and protein kinase C (PKC) at postsynaptic sites in neurons. In this report we focus on the mechanism of interaction between AKAP79 and PKC. We show that neither lipid activators nor kinase activation are required for association with AKAP79. The anchoring protein binds and inhibits the conserved catalytic core of PKCbetaII. AKAP79 also associates with conventional, novel and atypical isoforms of PKC in vitro and in vivo, and immunofluorescence staining of rat hippocampal neurons demonstrates that the murine anchoring-protein homologue AKAP150 is co-distributed with PKCalpha/beta, PKCepsilon or PKCiota. Binding of the AKAP79(31-52) peptide, which inhibits kinase activity, exposes the pseudosubstrate domain of PKCbetaII, allowing endoproteinase Arg-C proteolysis in the absence of kinase activators. Reciprocal experiments have identified two arginine residues at positions 39 and 40 that are essential for AKAP79(31-52) peptide inhibition of PKCbetaII. Likewise, the same mutations in the full-length anchoring protein reduced inhibition of PKCbetaII. Thus AKAP79 associates with multiple PKC isoforms through a mechanism involving protein-protein interactions at the catalytic core where binding of the anchoring protein inhibits kinase activity through displacement of the pseudosubstrate.
A激酶锚定蛋白AKAP79可协调环磷酸腺苷(cAMP)依赖性蛋白激酶、磷酸酶2B(PP2B/钙调神经磷酸酶)和蛋白激酶C(PKC)在神经元突触后位点的定位。在本报告中,我们重点研究AKAP79与PKC之间的相互作用机制。我们发现,与AKAP79结合既不需要脂质激活剂,也不需要激酶激活。该锚定蛋白可结合并抑制PKCβII的保守催化核心。在体外和体内,AKAP79还可与PKC的传统型、新型和非典型亚型结合,对大鼠海马神经元进行免疫荧光染色显示,小鼠锚定蛋白同源物AKAP150与PKCα/β、PKCε或PKCι共分布。抑制激酶活性的AKAP79(31-52)肽的结合会暴露PKCβII的假底物结构域,从而在没有激酶激活剂的情况下允许内肽酶Arg-C进行蛋白水解。相互实验确定了39位和40位的两个精氨酸残基,它们是AKAP79(31-52)肽抑制PKCβII所必需的。同样,全长锚定蛋白中的相同突变也会降低对PKCβII的抑制作用。因此,AKAP79通过一种机制与多种PKC亚型结合,该机制涉及在催化核心处的蛋白质-蛋白质相互作用,其中锚定蛋白的结合通过假底物的置换来抑制激酶活性。